Financial Information

Cash Flow

Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Net income (Loss) $ (1,360,089) $ (1,218,449)
Adjustments to reconcile net (loss) to net cash (used) by operating activities    
Change in fair value of derivative liability (502,830)
Amortization of debt discount 315,828 91,557
Amortization of intangibles 195,775
Amortization and depreciation
Bad debt provision (recovery) (49,119)
(Gain) loss on discontinued operations and disposal (594,752)
Loss on settlement of notes and other payables 553,222
Stock issued for services 411,500
Stock compensation expense 273,570 162,741
Common stock issued for services 838,938
Warrant revaluation 128,375
Issuance of warrants for services 20,747  
Changes in Assets and Liabilities    
Trade accounts receivable 29,137 95,092
Other receivables 2,250
Product deposit (16,802) (16,500)
Inventory (341,358) (546,891)
Other current assets (270,006)
Deferred revenue 45,905
Deferred tax liability 4,000
Accounts payable and accrued expenses 293,150 (227,227)
Net cash (used) by operating activities of continuing operations (865,020) (817,216)
Net cash used in operating activities of discontinued operations (40,498)
Net cash (used in) provided by operating activities (905,518) (817,216)
Purchase of subsidiary, net of cash received (148,555)
Purchase of intangible assets licenses (100,000)
Proceeds from sale of legacy business 390,000
Net cash provided by (used in) investing activities 141,445
Investment in subsidiary by noncontrolling interest, net 156,266 63,378
Proceeds from notes payable 325,000 878,855
Proceeds from convertible notes payable 550,000
Repayment of convertible note payable (100,000)
Repayment of notes payable (232,559) (662,796)
Proceeds from options exercise
Sale of common stock and warrants 673,245
Exercise of stock options 4,080
Purchase of treasury stock (76,648)
Net cash provided by financing activities 802,787 776,034
Net increase in cash 38,714 (41,182)
Cash at beginning of the period 141,379 182,561
Cash at end of the period 180,093 141,379
Supplemental Disclosure of Cash Flow Information    
Cash paid during the period for interest 4,383 4,723
Issuance of company stock for notes and other payables 242,192
Stock repurchase from shareholder and retirement of stock 460,000
Conversion of liability as consideration on sale of legacy business 150,000
Warrants issued in relation to debt 533,691
Conversion of notes payable 344,641
Purchase of asset license accrued 100,000
Conversion of equity invested in subsidiary to common stock and warrants 303,419
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance $ 261,357